ICU Medical, Inc. (ICUI) stock prices updated...
 

ICU Medical, Inc. stock price

ICU Medical, Inc. latest news:


  • 01/05/2018 15:09:02

    BRIEF-ICU Medical Says Board Increased Size Of Board From 7 To 9

    Icu Medical Inc(ICUI): * ICU MEDICAL SAYS BOARD INCREASED SIZE OF BOARD FROM 7 TO 9 AND ELECTED DONALD ABBEY AND DAVID HOFFMEISTER AS NEW DIRECTORS - SEC FILING Source text: Further company coverage:

  • 12/21/2017 14:44:21

    Celgene stock falls after Revlimid cancer study fails

    Celgene Corp. shares declined more than 4% in late trading Thursday after revealing that a phase II study of a cancer drug failed to meet its goal. Celgene said that a study testing Revlimid on follicular lymphoma did not meet the desired endpoint. Revlimid is already approved for other forms of cancer, and is Celgene's biggest drug in terms of revenue, producing $7 billion in sales in 2016 before price hikes last year. "We remain committed to advancing our broad pipeline of novel therapies to establish new standards of care for patients with lymphoma," Chief Medical Officer Jay Backstrom said in the announcement. Celgene stock fell to $103.50 in late trading, after closing with a 0.4% decline at $107.88.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Ideal Power Inc.IPWR | Identiv, Inc.INVE | Idera Pharmaceuticals, Inc.IDRA | IDEXX Laboratories, Inc.IDXX | iDreamSky Technology LimitedDSKY | IF Bancorp, Inc.IROQ | Ignite Restaurant Group, Inc.IRG | Ignyta, Inc.RXDX | II-VI IncorporatedIIVI | iKang Healthcare Group, Inc.KANG |